Decision Point - TomLand

Decision Point Associated with Pancreatic Cancer. Posted on April 19, 2012 View this journey (12 Experiences)

Following failure of the Gemzar treatment we discussed several options. I was all set up to try the Folfirinox treatment, another type of chemo that is proven effective with my type cancer. It also has much stronger side effects.

The next morning the Doc called with some new alternatives. One is only available at Sloan-Kettering at the moment but sounds like it has good promise. Doc expects it to be available locally in the next 4 to 6 months. If it continues to show good promise I may switch to it when available locally.

The third good choice is another study similar to the previous one only it is a blind study - I will not know if I have the test drug or not. The base drug is Capecitabine. This is FDA approved for colon and breast cancer but not for pancreatic - what I have. I know I will receive that drug. It is in pill form and is noted as having small side effects. This has been used some for Pancreatic cancer with good effects. The variable drug is Ruxolitinib, a new drug that is not approved by FDA for any treatment. It also is in pill form with few side effects expected.

I decided on the third choice which allows me to stay at home as well as has good promise to kill the tumors.

2 people found this helpful
1 Comment
  • FreeBird's Avatar

    The third choice listed is exactly the clinical trial offered to my dad after failure of Gemzar. TomLand may no longer be around in body. But he's still here in spirit, helping people.

    about 8 years ago

Read more Pancreatic Cancer experiences about Decision Point.

Read and answer Pancreatic Cancer questions.